Cancer Biomarkers: Clinical Aspects and Laboratory Determination
Autor: | Lakshmi V. Ramanathan, Martin Fleisher, Michael J. Duffy |
---|---|
EAN: | 9780128243039 |
eBook Format: | ePUB/PDF |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 07.06.2022 |
Kategorie: | |
Schlagworte: | ?2-hydroxyglutarate All-cause mortality Artificial intelligence Assay interference Autoantibody Biologic variation Biomarkers Brain tumors CA 125: micro-RNA CAR T cell Cancer Cancer patients Childhood malignancies Chimeric antigen recept |
144,00 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Cancer Biomarkers: Clinical Aspects and Laboratory Determination provides a comprehensive overview of current biomarkers for cancer detection, monitoring and recurrence, focusing on emerging technologies, impacts on the field, and selected biomarkers currently used in clinical practice. The content highlights current laboratory tests used in the management of adult and pediatric cancer patients. In addition, it investigates the role of Circulating Tumor Cells and circulating tumor DNA as biomarkers in cancer management as well as cytokines in monitoring response to CAR T therapies. This title is a perfect reference for clinical pathologists, laboratory scientists, medical technologists, physicians specializing in oncology, internal medicine, family practice and transplant medicine, resident physicians, medical students, nurse practitioners and clinical chemists. - Provides insights into the overall complexity that the cancer patient presents and how laboratory tests are used in the management of care - Discusses current and new technologies applicable to cancer biomarker evaluation, including the use of non-traditional specimens like saliva, fluids and uterine lavage - Reviews current trends in liquid biopsy and cancer biomarkers - Provides a roadmap for bringing new technologies and markers from the bench to the bedside in the quest for finding the ideal tumor marker